6. Lisztwan J, Imbert G, Wirbelauer C, Gstaiger M, Krek W (1999) The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin- protein ligase activity. Genes Dev 13: 1822–1833. 7. Schofield CJ, Ratcliffe PJ (2004) Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5: 343–354. 8. Ivan M, Kondo K, Yang H, Kim W, Valiando J, et al. (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292: 464–468. 9. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, et al. (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292: 468–472. 10. Kaelin WG, Jr. (2008) The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 8: 865–873. 11. Czyzyk-Krzeska MF, Meller J (2004) von Hippel-Lindau tumor suppressor: not only HIF’s executioner. Trends Mol Med 10: 146–149. 12. Okuda H, Saitoh K, Hirai S, Iwai K, Takaki Y, et al. (2001) The von Hippel- Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C. J Biol Chem 276: 43611–43617. 13. Grosfeld A, Stolze IP, Cockman ME, Pugh CW, Edelmann M, Kessler B, Bullock AN, Ratcliffe PJ, Masson N (2007) Interaction of Hydroxylated Collagen IV with the von Hippel-Lindau Tumor Suppressor. J Biol Chem 282: 13264–13269. 14. Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, et al. (1998) The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell 1: 959–968. 15. Yang H, Minamishima YA, Yan Q, Schlisio S, Ebert BL, et al. (2007) pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2. Mol Cell 28: 15–27. 16. Chitalia VC, Foy RL, Bachschmid MM, Zeng LL, Panchenko MV, et al. (2008) Jade-1 inhibits Wnt signaling by ubiquitilating b-catenin and mediates Wnt pathway inhibition by pVHL. Nat Cell Biol 10: 1208–1216. 17. Pucci S, Bonanno E, Pichiorri F, Angeloni C, Spagnoli LG (2004) Modulation of different clusterin isoforms in human colon tumorigenesis, Oncogene 23: 2298–2304. 18. Shannan B, Seifert M, Leskov K, Willis J, Boothman D, et al. (2006) Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death and Diff 13: 12–19. 19. Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA (2003) Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem 274: 11590–11600. pVHL Mediates Ubiquitination of nCLU 20. de Silva HV, Harmony JA, Stuart WD, Gil CM, Robbins J (1990) A Apolipoprotein J: structure and tissue distribution. Biochemistry 29: 5380–5389. 21. Klock G, Baiersdo¨rfer M, Koch-Brandt C (2009) Chapter 7: Cell protective functions of secretory Clusterin (sCLU). Adv Cancer Res 104: 115–138. 22. Bettuzzi S, Rizzi F (2009) Chapter 5: Nuclear CLU (nCLU) and the fate of the cell. Adv Cancer Res 104: 59–88. 23. Nakamura E, Abreu-e-Lima P, Awakura Y, Inoue T, Kamoto T, et al. (2006) Clusterin Is a Secreted Marker for a Hypoxia-Inducible Factor-Independent Function of the von Hippel-Lindau Tumor Suppressor Protein. Am J Pathol 168: 574–584. 24. Xue J, Li X, Jiao S, Wei Y, Wu G, Fang J (2010) Prolyl hydroxylase-3 is down- regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity. Gastroenterology 138: 606–615. 25. Kuznetsova AV, Meller J, Schnell PO, Nash JA, Ignacak ML, et al. (2003) von Hippel–Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination. Proc Natl Acad Sci USA 100: 2706–2711. 26. Rizzi F, Caccamo AE, Belloni L, Bettuzzi S (2009) Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cells. J Cell Physiol 219: 314–323. 27. Yang W-L, Zhang X, Lin H-K (2010) Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development. Oncogene 29: 4493–4503. 28. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD (2006) Sensing of Lys 63- linked polyubiquitination by NEMO is a key event in NF-kB activation. Nature Cell Biol 8: 398–406. 29. Pickart CM (2001) Mechanisms underlying ubiquitination. Annu Rev Biochem 70: 503–533. 30. van Wijk SJ, de Vries SJ, Kemmeren P, Huang A, Boelens R, et al. (2009) A comprehensive framework of E2–RING E3 interactions of the human ubiquitin–proteasome system. Mol Syst Biol 5: 295. 31. Nath D, Shadan S (2009) The ubiquitin system. Nature 458: 421. 32. Bhoj VG, Chen ZJ (2009) Ubiquitylation in innate and adaptive immunity. Nature 458: 430–437. 33. Geetha T, Kenchappa RS, Wooten MW, Carter BD (2005) TRAF6-mediated ubiquitination regulates nuclear translocation of NRIF, the p75 receptor interactor. EMBO J 24: 3859–3868. PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e35848